Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
300363 Porton Pharma Solutions
- 14.79
- -0.34-2.25%
Market Closed May 9 15:00 CST
8.07BMarket Cap-40.97P/E (TTM)
15.14High14.75Low75.67KlotVolume15.13Open15.13Pre Close112.44MTurnover1.51%Turnover RatioLossP/E (Static)545.46MShares21.9852wk High1.55P/B7.40BFloat Cap10.9152wk Low18.16Limit Up500.45MShs Float107.99Historical High12.10Limit Down2.58%Amplitude4.99Historical Low--Dividend TTM14.86Avg Price40.54KlotAsk--Div YieldTTM100Lot Size33.64KlotBid
Porton Pharma Solutions Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 18.21%801.16M | -17.87%3.01B | -30.02%2.13B | -42.19%1.35B | -50.81%677.72M | -47.87%3.67B | -41.79%3.04B | -40.25%2.34B | -4.50%1.38B | 126.55%7.03B |
| Operating revenue | 18.21%801.16M | -17.87%3.01B | -30.02%2.13B | -42.19%1.35B | -50.81%677.72M | -47.87%3.67B | -41.79%3.04B | -40.25%2.34B | -4.50%1.38B | 126.55%7.03B |
| Other operating revenue | ---- | 144.93%23.11M | ---- | -47.90%3.19M | ---- | -65.04%9.44M | ---- | -56.97%6.12M | ---- | -13.39%26.99M |
| Total operating cost | -0.69%810.27M | -4.55%3.22B | -8.61%2.4B | -18.02%1.58B | -23.69%815.92M | -28.68%3.37B | -23.73%2.63B | -20.48%1.93B | 6.02%1.07B | 90.49%4.73B |
| Operating cost | 3.48%590.21M | 4.42%2.27B | -0.58%1.63B | -11.46%1.1B | -16.83%570.35M | -35.64%2.18B | -33.75%1.64B | -33.51%1.24B | -6.90%685.79M | 85.60%3.38B |
| Operating tax surcharges | 89.70%7.46M | -47.88%23.19M | -52.95%18.7M | -55.25%12.14M | -71.63%3.93M | -29.05%44.49M | 143.88%39.76M | 119.70%27.14M | 113.34%13.86M | 346.12%62.71M |
| Operating expense | -0.42%35.04M | 10.48%159.88M | 5.11%112.96M | -2.81%77.11M | -2.68%35.18M | -28.82%144.71M | -28.81%107.47M | -16.90%79.34M | -31.86%36.15M | 109.54%203.29M |
| Administration expense | -24.69%89.43M | -27.45%397.93M | -24.19%331.79M | -29.25%228.42M | -24.65%118.75M | -9.25%548.46M | 11.20%437.65M | 41.90%322.86M | 63.36%157.59M | 108.68%604.37M |
| Financial expense | 366.14%15.23M | 234.85%29.49M | 281.20%40.96M | 98.58%-700.11K | -67.00%3.27M | 122.80%8.81M | 45.88%-22.6M | 5.00%-49.36M | -9.48%9.9M | -1,944.39%-38.63M |
| -Interest expense (Financial expense) | -8.22%14.26M | 40.55%62.06M | 76.73%46.3M | 93.28%31.21M | 147.60%15.54M | 59.24%44.15M | 30.71%26.2M | 39.38%16.15M | -57.31%6.27M | 27.76%27.73M |
| -Interest Income (Financial expense) | 63.22%-4.05M | 58.39%-24.08M | 56.69%-21.97M | 52.68%-17.62M | 41.12%-11.01M | -153.48%-57.88M | -266.27%-50.71M | -404.15%-37.24M | -445.94%-18.7M | -59.62%-22.83M |
| Research and development | -13.66%72.9M | -25.15%338.49M | -37.34%266.46M | -45.91%168.39M | -49.13%84.43M | -12.95%452.23M | -5.64%425.22M | 10.97%311.3M | 58.20%165.97M | 96.92%519.51M |
| Credit Impairment Loss | -7.12%-2.27M | -156.02%-19.41M | -125.81%-9.88M | -106.05%-1.51M | -139.28%-2.12M | 202.63%34.64M | 462.44%38.3M | 128.12%25M | 163.21%5.39M | 18.47%-33.75M |
| Asset Impairment Loss | -145.53%-71.87K | -40.28%-133.43M | 32.11%-20.38M | -9.07%-20.52M | -58.85%157.84K | -424.39%-95.12M | -449.55%-30.02M | -242.67%-18.82M | 107.58%383.54K | 19.45%-18.14M |
| Other net revenue | 264.85%5.26M | -445.35%-134.12M | -150.06%-18.13M | -157.27%-14.5M | -132.62%-3.19M | 36.75%-24.59M | 255.95%36.21M | 125.91%25.31M | 179.98%9.79M | 30.67%-38.89M |
| Fair value change income | 54.91%-651.8K | -115.96%-1.78M | -103.95%-441.65K | -105.70%-614.25K | ---1.45M | -49.71%11.18M | 400.92%11.18M | 382.75%10.77M | ---- | 294.11%22.23M |
| Invest income | 76.49%-1.51M | -6.35%-13.62M | -21.87%-12.1M | 20.59%-8.82M | -6.23%-6.42M | 57.89%-12.81M | 53.68%-9.93M | 12.65%-11.1M | -65.62%-6.05M | -144.76%-30.42M |
| -Including: Investment income associates | 54.67%-2.91M | 33.96%-13.62M | 29.88%-12.1M | 24.33%-8.82M | 2.61%-6.42M | 33.42%-20.62M | 21.54%-17.26M | 12.20%-11.65M | -56.59%-6.59M | 1.17%-30.98M |
| Asset deal income | -868.28%-322.52K | -243.25%-770.24K | -233.71%-531.26K | -1,013.65%-180.46K | ---33.31K | 423.54%537.68K | 298.56%397.31K | --19.75K | ---- | 103.20%102.7K |
| Other revenue | 51.31%10.09M | -5.65%34.89M | -4.10%25.21M | -11.80%17.15M | -33.71%6.67M | 75.35%36.97M | 120.78%26.29M | 171.04%19.45M | 263.12%10.06M | 18.31%21.09M |
| Operating profit | 97.28%-3.84M | -227.36%-342.5M | -166.01%-294.22M | -156.67%-245.44M | -144.42%-141.39M | -88.13%268.91M | -74.52%445.72M | -68.80%433.07M | -24.57%318.32M | 300.48%2.27B |
| Add:Non operating Income | 250.21%1.77M | 145.88%2.36M | 51.29%1.59M | 162.74%1.14M | 260.77%504.37K | -55.28%960.78K | -68.03%1.05M | -74.09%432.91K | -85.49%139.8K | -2.97%2.15M |
| Less:Non operating expense | -40.00%1M | 45.46%33.91M | -59.91%5.54M | -60.42%3.41M | 82.17%1.67M | 8.85%23.31M | -20.81%13.82M | -21.91%8.61M | -82.63%919.37K | 12.85%21.42M |
| Total profit | 97.84%-3.08M | -251.71%-374.05M | -168.87%-298.17M | -158.30%-247.7M | -144.90%-142.56M | -89.02%246.56M | -75.05%432.95M | -69.18%424.9M | -23.97%317.54M | 309.20%2.25B |
| Less:Income tax cost | 223.35%22.47M | -111.34%-8.06M | -144.40%-31.31M | -146.88%-31.28M | -147.87%-18.21M | -77.04%71.05M | -69.02%70.51M | -67.50%66.72M | -36.02%38.05M | 322.40%309.38M |
| Net profit | 79.45%-25.55M | -308.52%-365.99M | -173.63%-266.86M | -160.42%-216.43M | -144.49%-124.35M | -90.94%175.52M | -75.96%362.44M | -69.47%358.18M | -21.97%279.49M | 307.17%1.94B |
| Net profit from continuing operation | 79.45%-25.55M | -308.52%-365.99M | -173.63%-266.86M | -160.42%-216.43M | -144.49%-124.35M | -90.94%175.52M | -75.96%362.44M | -69.47%358.18M | -21.97%279.49M | 307.17%1.94B |
| Less:Minority Profit | 27.86%-21.27M | 14.35%-78.24M | 32.41%-60.43M | 11.12%-46.39M | -19.82%-29.48M | -32.40%-91.34M | -27.43%-89.42M | -33.60%-52.19M | -3.78%-24.6M | -42.76%-68.99M |
| Net profit of parent company owners | 95.48%-4.28M | -207.83%-287.75M | -145.68%-206.43M | -141.43%-170.04M | -131.20%-94.87M | -86.69%266.86M | -71.36%451.86M | -66.15%410.37M | -20.37%304.09M | 282.78%2.01B |
| Earning per share | ||||||||||
| Basic earning per share | 94.12%-0.01 | -208.16%-0.53 | -145.78%-0.38 | -140.79%-0.31 | -130.36%-0.17 | -86.76%0.49 | -71.38%0.83 | -65.92%0.76 | -20.00%0.56 | 281.44%3.7 |
| Diluted earning per share | 94.12%-0.01 | -208.16%-0.53 | -145.78%-0.38 | -140.79%-0.31 | -130.36%-0.17 | -86.72%0.49 | -71.18%0.83 | -65.61%0.76 | -20.00%0.56 | 280.41%3.69 |
| Other composite income | 183.09%19.72M | -220.70%-30.13M | 5.61%-5.22M | -319.18%-21.83M | -258.42%-23.74M | -20.96%24.96M | 78.52%-5.53M | 84.03%9.96M | -5.00%14.98M | 295.96%31.58M |
| Other composite income of parent company owners | 183.10%19.72M | -220.71%-30.14M | 5.73%-5.22M | -319.29%-21.83M | -258.42%-23.73M | -20.94%24.97M | 78.51%-5.54M | 83.88%9.95M | -5.01%14.98M | 296.03%31.58M |
| Other composite income of minority owners | 26.04%-844.64 | 292.90%7.58K | -449.70%-5.48K | -81.29%829.27 | -263.36%-1.14K | -305.12%-3.93K | 172.28%1.57K | 321.63%4.43K | 155.63%699.09 | 127.49%1.91K |
| Total composite income | 96.06%-5.83M | -297.59%-396.12M | -176.23%-272.09M | -164.72%-238.25M | -150.29%-148.09M | -89.81%200.48M | -75.91%356.91M | -68.77%368.14M | -21.26%294.47M | 328.32%1.97B |
| Total composite income of parent company owners | 113.02%15.44M | -208.93%-317.89M | -147.42%-211.65M | -145.65%-191.86M | -137.17%-118.61M | -85.67%291.82M | -71.24%446.32M | -65.48%420.33M | -19.76%319.07M | 301.14%2.04B |
| Total composite income of minority owners | 27.86%-21.27M | 14.36%-78.23M | 32.41%-60.44M | 11.11%-46.39M | -19.83%-29.48M | -32.41%-91.35M | -27.43%-89.42M | -33.59%-52.19M | -3.77%-24.6M | -42.73%-68.99M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.